HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands

Neurology

Volumn 60, Issue 4, 2003, Pages 647-651

  Kikuchi, S ^a   Fukazawa, T ^b   Niino, M ^a   Yabe, I ^a   Miyagishi, R ^a   Hamada, T ^b   Hashimoto, S A ^c   Tashiro, K ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hokuyukai Neurology Hospital   (Japan)

^c VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENDER; HUMAN; IMMUNOGENETICS; JAPAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0037465464     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000048202.09147.9E     Document Type: Article

References (40)

1. Andersson M, Alvarez-Cermeno J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994;57:897-902.
2. Fukazawa T, Kikuchi S, Sasaki H, et al. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. J Neurol Sci 1998;158:209-214.
3. Nakashima I, Fujihara K, Itoyama Y. Oligoclonal IgG bands in Japanese multiple sclerosis patients. J Neurol Sci 1999;101:205-206.
4. Tiwari JL, Terasaki PI. Multiple sclerosis. In: Tiwari JL, Terasaki PI, eds. HLA and disease associations. New York: Springer-Verlag, 1985: 152-167.
5. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994;36:S15-S17.
6. Compston DAS, Kellar Wood H, Robertson N, Sawcer S, Wood NW. Genes and susceptibility to multiple sclerosis. Acta Neurol Scand [Suppl] 1995;161:43-51.
7. Coraddu F, Reyes-Yanez MP, Parra A, et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol 1998;87:130-135.
8. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Örnek Ì, Vaughan R, Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997;55:59-65.
9. Marrosu MG, Muntoni F, Murru MR, et al. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology 1988;38:1749-1753.
10. Marrosu MG, Murru MR, Costa G, et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet 1997;61:454-457.
11. Kira J, Kanai T, Nishimuta Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996;40:569-574.
12. Ono T, Zambenedetti MR, Yamasaki K, et al. Molecular analysis of HLA class I (HLA-A and B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). Tissue Antigens 1998;52:539-542.
13. Fukazawa T, Yamasaki K, Ito H, et al. Both the HLA-DPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 2000;55:199-205.
14. Fukazawa T, Hamada T, Tashiro K, et al. HLA profiles of multiple sclerosis in Hokkaido, the northernmost island of Japan. Acta Neurol Scand 1992;86:517-520.
15. Fukazawa T, Kikuchi S, Sasaki H, et al. Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele. J Neurol 2000;247:175-178.
16. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
17. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 1993;88:184-189.
18. Fukazawa T, Hamada T, Kikuchï S, Sasaki H, Tashiro K. Antineutrophil cytoplasmic antibodies and the optic-spinal cord of multiple sclerosis in Japan. J Neurol Neurosurg Psychiatry 1996;61:203-204.
19. Fukazawa T, Kikuchi S, Sasaki H, et al. Anti-nuclear antibodies and the optic spinal form of multiple sclerosis. J Neurol 1997;244:483-488.
20. Fukazawa T, Tashiro K, Hamada T, et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern Med 1992;31:349-352.
21. Buyse I, Decorte R, Baens M, et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993;41:1-14.
22. Mehta PD, Patrick BA, Black J. Detection of oligoclonal IgG bands in unconcentrated CSF by isoelectric focusing in agarose gel and silver staining. J Neurosci Methods 1986;16:277-282.
23. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien P, Kurlnd L. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted Country, Minnesota. Neurology 1994;44:28-33.
24. Weinshenker BG, Wingerchuk DM, Liu Q, et al. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology 1997;49:378-385.
25. Zeman AZJ, Kidd D, McLean BN, et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:27-30.
26. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000;48:211-219.
27. Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL. Multiple sclerosis: genomic rewards. J Neuroimmunol 2001;113:171-184.
28. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Lab Sci 1995;32:121-182.
29. Wucherpfennig KW, Sette A, Southwood S, et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cells clones. J Exp Med 1994;179:279-290.
30. Ito K, Bian HJ, Molina M, et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med 1996;183:2635-2644.
31. Macklin WB, Campagnoni CW, Deininger PL, Gardinier MV. Structure and expression of the mouse myelin proteolipid protein gene. J Neurosci Res 1987;18:383-394.
32. Forsthuber TG, Shive CL, Wienhold W, et al. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J Immunol 2001;167:7119-7125.
33. Stendahl-Brodin L, Link H. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1980;43:102-105.
34. Pittilä T, Nurmikko T. CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosis. Acta Neurol Scand 1995;92:468-471.
35. Pender MP, Greer JM, Csurbes PA, et al. T-Cell reactivity to peptides of proteolipid protein and myelin basic protein in multiple sclerosis. Ann Neurol 1996;40:552.
36. Farrel MA, Kaufmann JCE, Gilbert JJ, Noseworthy JH, Armstrong HA, Ebers GC. Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation. Neurology 1985;35:212-218.
37. Müller FAJ, Hänny PE, Wichmann W, et al. Cerebrospinal fluid immunoglobulins and multiple sclerosis. Correspondence with magnetic resonance imaging and visually evoked potential changes. Arch Neurol 1989;46:367-371.
38. Fukazawa T, Moriwaka F, Suguyama K, Hamada T, Tashiro K. Cerebrospinal fluid IgG profiles and multiple sclerosis in Japan. Acta Neurol Scand 1993;88:178-183.
39. Sellebjerg F, Jensen J, Madsen HO, Svejgaard A. HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis. Tissue Antigens 2000;55:312-318.
40. Zu X-h, McFarlin DE. Oligoclonal bands in CSF: twins with MS. Neurology 1984;34:769-774.